SCHEMBL5666286

SCHEMBL5666286

COc1ccccc1OC1C(=O)CC(c2ncccn2)NC1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
HTR1A P08908 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
SLC6A3 Q01959 1/20 0.35
NPC1 O15118 3/20 0.34
PDCD1 Q15116 2/20 0.34
CD274 Q9NZQ7 2/20 0.34
PDE4A P27815 2/20 0.34
PDE4B Q07343 2/20 0.34
PDE4C Q08493 2/20 0.34
PDE4D Q08499 2/20 0.34
PKM P14618 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532744 0.80 L3MBTL1 (0.39) RAB9AL3MBTL1HTR1ASLC6A2SLC6A4
SCHEMBL627191 0.67 RAB9A (0.35) RAB9AL3MBTL1HTR1ASLC6A2SLC6A4
SCHEMBL9423732 0.66 MEN1 (0.43) RAB9AKDM4EALDH1A1LMNAHTT
SCHEMBL7209808 0.66 CA2 (0.46) RAB9AL3MBTL1PDE4APDE4BPDE4C
SCHEMBL7197852 0.64 SIRT2 (0.49) RAB9APDE4APDE4BPDE4CPDE4D
SCHEMBL7295427 0.63 PLAT (0.32) L3MBTL1PDE4APDE4BPDE4CPDE4D
SCHEMBL7296783 0.62 DDB1 (0.37) HTR1ASLC6A2SLC6A4SLC6A3PDE4A
SCHEMBL7293888 0.60 CA12 (0.35) RAB9AL3MBTL1SLC6A2SLC6A4PDE4A
SCHEMBL7303598 0.60 CA12 (0.35) RAB9AHTR1APDE4APDE4BPDE4C
SCHEMBL6819349 0.59 SLC6A2 (0.42) SLC6A2SLC6A4PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345920-B1 NOVEL SULFAMIDES AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-04-12 EP disclosed